Journalists must meet the following criteria to apply for one or both options:
- News media reporters, writers, producers and editors with staff credentials from newspapers, magazines, online news services, wire services, radio or television networks, individual stations and blogs that appear on a media outlet's website that produce daily or weekly health/medical/science news.
- Journalists with bylined news reports published on news wire services and news media who produce materials for bi-monthly, monthly, or quarterly publications or programs will be considered on a case-by-case basis.
- Freelance writers with approved credentials (must provide three bylined articles/clip links published by accredited media outlets within the past 6 months) and/or a verifiable assignment letter from an accredited media outlet. Letters of assignment must include contact information for the assigning editor at the media outlet.
- Bloggers who provide daily or weekly coverage of health news but are not affiliated with a major news outlet will be considered on a case-by-case basis.
- Writers/editors or contributors for websites not considered mainstream media but report regularly on breaking health news will be considered on a case-by-case basis.
- All other applications will be considered on a case-by-case basis.
Journalists and other media representatives who may not qualify for access to the password protected newsroom or the pre-embargo media email list, may receive our news materials via email at the time of embargo via Email Alerts.
Options must be applied for separately and you must include the http when adding your URL to either form:
Access to password protected newsroom 24/7 with free access to AHA/ASA Journals.
Access to AHA/ASA news materials pre-embargo via email distribution.
Who cannot register for access to embargoed media materials:
- Industry representatives and financial/industry analysts.
- Writers/editors or contributors for patient publications created and distributed by industry, such as pharmaceutical companies or device manufacturers.
- Staff from public relations firms, advertising agencies or production companies.
- Representatives of corporate, academic or hospital public relations/advertising/marketing/communications/media departments.
- Editors, writers of newsletters created and distributed by universities and hospitals for the public/patient/student.
- Hospitals/universities or other online sites reporting only their own news/press materials.
- In-house and/or industry newsletters/magazines/websites supported by industry or publications supported by a retail chain store, such as a drug store.
- Publishers (who are not reporters) of peer-reviewed medical journals and other media outlets that cover health news.
- Bloggers who do not report daily or weekly on breaking health news.
- Wire or other online services offering syndicated or mass distribution of AHA/ASA embargoed media materials to journalists and non-journalists.
- Staff or representative for medical education companies.
Embargo Rules for News Media:
- By accepting AHA/ASA embargoed materials through email, fax, regular mail, from the AHA’s online password-protected embargoed online newsroom site or via media registration for scientific meetings, reporters agree to follow the AHA/ASA embargo policies.
- AHA/ASA embargoed information is provided to facilitate the development of news content. Materials may not be published prior to the embargo time and can only be distributed to experts for media interviews. Journalists sharing information with expert sources bear the responsibility of ensuring those sources abide by all AHA policies.
- Failure to abide by AHA/ASA embargo policies may result in suspension of access to: AHA/ASA embargoed materials, media credentials at AHA/ASA scientific meetings and pre-embargo interviews with AHA/ASA volunteer experts. The media outlet that employs a reporter who has broken an embargo also may be penalized.
- Once a media outlet/reporter has been suspended, it is the responsibility of the reporter and/or media outlet to reapply to receive embargoed media materials after the suspension period ends.